Merck To Pay $100 Million In NuvaRing Settlement

WASHINGTON -- Merck & Co. will pay $100 million to resolve thousands of lawsuits alleging its NuvaRing contraceptive device causes potentially fatal blood clots, according to a settlement announced Friday. The settlement addresses as many as 3,800 cases in federal and state courts in Missouri and New Jersey, as well as certain unfiled claims that meet specific eligibility requirements. The $100 million payout, averaging more than $58,000 per case, will be contingent upon at least 95 percent of t...